![]() |
市場調査レポート
商品コード
1518340
タンパク質発現市場:システム別、オファリング別、用途別、エンドユーザー別 - 2030年までの世界予測Protein Expression Market by System (Mammalian, Non-mammalian ), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User - Global Forecast to 2030 |
||||||
カスタマイズ可能
|
タンパク質発現市場:システム別、オファリング別、用途別、エンドユーザー別 - 2030年までの世界予測 |
出版日: 2024年07月01日
発行: Meticulous Research
ページ情報: 英文 270 Pages
納期: 5~7営業日
|
タンパク質発現市場は、2023年から2030年までのCAGRが7.6%で、2030年までに50億米ドルに達すると予測されています。
広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、機会、課題の分析を提供します。
バイオ医薬品市場の成長、組換えタンパク質に対する需要の高まり、政府の支援策、ライフサイエンス研究への資金援助がこの市場の成長を促進しています。しかし、タンパク質ベースの研究にかかるコストの高さと熟練した専門家の不足が、この市場の成長を抑制しています。さらに新興国は、タンパク質発現市場で活動する企業に大きな成長機会を提供すると期待されています。しかし、実験室での形質転換パラメータの複雑さが、市場成長を制限する課題となっています。
(注:上位5社のSWOT分析を提供予定です)
Protein Expression Market Size, Share, Forecast, & Trends Analysis by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect]), Offering (Kits & Reagents, Competent Cells, Services), Application, and End User - Global Forecast to 2030
The protein expression market is projected to reach $5 billion by 2030 at a CAGR of 7.6% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growing biopharmaceutical market, the rising demand for recombinant proteins, supportive government initiatives, and funding for life science research are driving the growth of this market. However, the high costs of protein-based research and the lack of skilled professionals restrain the growth of this market. Furthermore, emerging economies are expected to offer significant growth opportunities for players operating in the protein expression market. However, complexities in laboratory transformation parameters are a challenge limiting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the protein expression market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.).
Based on system, in 2023, the Chinese Hamster Ovary (CHO) cell line segment is expected to account for the largest share of the mammalian protein expression market. The large market share of this segment is attributed to the popularity of CHO cell lines in the production of biologics, the high similarity of CHO cells to the human cell system, and the high reproducibility of CHO cells.
Based on offering, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the increasing outsourcing of operations by pharma & biotech companies, the rising demand for biopharmaceuticals, collaborations between industry and academia for rapid bioproduction, and the growing demand for recombinant proteins in the non-healthcare sector.
Based on application, in 2023, the therapeutic segment is estimated to account for the largest share of the protein expression market. The large market share of this segment is attributed to the increasing incidence of diseases requiring therapeutic approaches for treatment and growth in R&D for therapeutic protein production.
Based on end user, in 2023, the contract research organizations segment is estimated to account for the largest share of the protein expression market. The large market share of this segment can be attributed to the increase in research activities and growth in outsourcing for the development of biologics.
An in-depth analysis of the geographical scenario in the protein expression market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the protein expression market. Furthermore, in 2023, the U.S. is expected to account for the major share of the protein expression market in North America. The large share of this market is primarily attributed to the presence of key market players, growth in R&D activities, and the significant volume of bioproduction.
Protein Expression Market Assessment-by System
Note: Other mammalian cell lines include baby hamster kidney cells, non-secreting murine myeloma cells, and PER.C6.
Protein Expression Market Assessment-by Offering
Protein Expression Market Assessment-by Application
Protein Expression Market Assessment-by End User
Protein Expression Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)